I believe it's supposed to take about 2 years for the UK to untangle themselves. I still think this is a tempest in a teapot.
I am curious as to how long after it goes to arbitration, which is where it will go I think, until it gets resolved. I imagine this would be something any potential suitor would want resolved before making an offer.
Yea thats what we want two high paying positions that add nothing to the bottom line. Hopefully they are just refills.
Totally agree. Sell the Co and join the boards of some small biotech's. Relax a bit and go fishing, or buy a small winery.
No different than our military power being used by other developed countries to protect them so they have money for their socialist programs.
I believe the US is in the beginning stages a a golden era for drug development by biotechs, and if the government stays out of the way prices will drop on their own as more and more drugs get approved.
Look at what has happened to GILD (which I also own) now that Harvoni has competition.
I believe that it was Joe who brought up that CRISPR is not as easy and cut and dry as it is promoted to be BUT these issues will be worked out and quickly. These are exciting times!
I am happy to have been wrong! Good call rpc356!!
Sentiment: Strong Buy
Great find, nice to read an article by someone who suffers from cancer, it gives it a more personal feel.
If it goes to arbitration and the allocation is deemed to be in line with the collaboration agreement, there should be some lawyers losing their jobs at EXEL or if done through a law firm start legal actions against that firm. EXEL is getting the shaft. IMHO.
I'm not counting on that. Traditionally EXEL will drop a few % after ASCO, that could especially be true after this huge run-up.
I will disagree as I am interested in hearing about his personal trades. Don't assume you know what everyone on this board wants. If you don't like his posts put him on ignore.
What I like is that Choueiri has not been one to overstate things, he seems like a very cautious guy.